41. 巨細胞性動脈炎 Giant cell arteritis Clinical trials / Disease details

臨床試験数 : 131 / 薬物数 : 139 - (DrugBank : 36) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 125

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05623592 (ClinicalTrials.gov)	November 23, 2022	8/11/2022	Methotrexateas Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocor ...	A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Met ...	Giant Cell Arteritis	Drug: Methotrexate;Drug: Sodium chloride	University of Bonn	NULL	Recruiting	18 Years	N/A	All	40	Phase 2	Germany
2	NCT03892785 (ClinicalTrials.gov)	January 27, 2020	26/3/2019	MEthotrexateVersus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Con ...	MEthotrexateVersus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Con ...	Giant Cell Arteritis	Drug: Prednisone treatment;Drug: Tocilizumab treatment;Drug: Methotrexate treatment;Other: Questionnair ...	Centre Hospitalier Universitaire Dijon	NULL	Recruiting	50 Years	N/A	All	230	Phase 3	France
3	EUCTR2018-002826-22-FR (EUCTR)	07/03/2019	21/11/2018	MEthotrexateversus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, con ...	MEthotrexateversus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, con ...	MedDRA version: 20.0;Level: LLT;Classification code 10018250;Term: Giant cell arteritis;System Orga ...	Trade Name: METOJECT Trade Name: RoActemra	CHU Dijon Bourgogne	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: no	200	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France
4	NCT01791153 (ClinicalTrials.gov)	July 22, 2013	12/2/2013	An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arte ...	A Phase III, Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Assess the Efficacy a ...	Giant Cell Arteritis	Drug: Tocilizumab;Drug: Prednisone;Drug: TocilizumabPlacebo;Drug: PrednisonePlacebo;Drug: Corticoste ...	Hoffmann-La Roche	NULL	Completed	50 Years	N/A	All	251	Phase 3	United States;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;S ...
5	NCT00004686 (ClinicalTrials.gov)	February 1994	24/2/2000	Phase II Randomized Study of Glucocorticoids With or Without Methotrexatefor Treatment of Giant Cell ...		Giant Cell Arteritis	Drug: methotrexate;Drug: prednisone	The Cleveland Clinic	NULL	Completed	50 Years	N/A	Both	300	Phase 2	NULL

First Previous1Next Last